While artificial intelligence tools continue to make our lives easier in many ways, they can also be used in the medical field, according to a recently published study. can lead to good developments. resembling.

The innovative ImmunoSEIRA sensor, which takes advantage of many different technologies and AI, is more effective due to its ability to distinguish diseases. definitive diagnoses can hinder progress.

ImmunoSEIRA holds promise for the future.

Developing tools to detect disease symptoms, known as biomarkers, has been difficult until now. Different proteins correctly separate and measure The barriers to accurate detection have been many, including the limitations of current technology, but this device can detect specific forms of proteins even in complex fluids such as human cerebrospinal fluid (CSF), making it suitable for clinical settings.

To create this advanced biomarker sensor, researchers at Professor Hatice Altuğ’s Bionanophotonic Systems Laboratory (BIOS) and Professor Hilal Lashuel’s Molecular Neurobiology and Neuroproteomics Laboratory (LMNN); protein biochemistry, They combined many fields of science, such as nanotechnology and artificial intelligence.

Unlike current biochemical approaches that rely on measuring levels of molecules, the device neural networks It focuses on detecting the abnormal structures of the disease and shows promise for the early detection and monitoring of diseases and the evaluation of treatment options at different stages of disease progression.